Want to see IN:SURAKSHA full AI Analyst Report?

Suraksha Diagnostic Ltd. (SURAKSHA) Price & Analysis

1 Followers

SURAKSHA Stock Chart & Stats

₹300.85

-₹13.40(-3.48%)

At close: Jan 08 4:00 PM EST

₹300.85

-₹13.40(-3.48%)

Day’s Range― - ―

52-Week Range₹224.10 - ₹333.65

Previous CloseN/A

Volume140.52K

Average Volume (3M)1.23K

Market Cap

₹14.25B

Enterprise Value₹14.87B

Total Cash (Recent Filing)₹263.48M

Total Debt (Recent Filing)₹1.30B

Price to Earnings (P/E)43.6

Beta1.12

Next Earnings

Aug 07, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)6.18

Shares Outstanding52,080,757

10 Day Avg. Volume1,073

30 Day Avg. Volume1,225

Financial Highlights & Ratios

PEG Ratio32.20

Price to Book (P/B)4.85

Price to Sales (P/S)3.82

P/FCF Ratio70.61

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)8.45

Revenue Forecast (FY)₹3.52B

Bulls Say, Bears Say

Bulls Say

Sustained Revenue GrowthMulti-year top-line expansion indicates durable demand and successful market penetration. Consistent mid-teens growth across FY24–FY25 and +12.5% in FY26 supports scale benefits, capacity utilization and long-term revenue visibility across a 2–6 month horizon.

Healthy Operating ProfitabilityRobust operating and EBITDA margins point to a structurally profitable service model with room to absorb cost shocks. Sustained mid-to-high teens operating margin supports reinvestment, pricing flexibility and the ability to sustain operations over the medium term.

Strong Operating Cash GenerationOperating cash flow exceeding accounting profit signals high earnings quality and resilient cash generation from core business. This provides durable funding for working capital and investment needs over months, and offers optionality for deleveraging or strategic spending.

Bears Say

Margin Compression & VolatilityMaterial margin deterioration and volatility suggest structural pressure from cost inflation, pricing dynamics or mix shifts. If persistent, lower gross and net margins will erode cash generation, reduce reinvestment capacity and compress sustainable returns over the medium term.

Rising Leverage TrendAn increasing debt trend reduces financial flexibility and raises interest expense risk. Even moderate leverage limits the firm's ability to respond to shocks, pursue acquisitive growth or accelerate capex without further funding, which matters for multi-month strategic plans.

Weak Free Cash Flow ConversionVery low FCF conversion despite strong operating cash flow implies heavy capex or working-capital demands. Persistent weak conversion constrains debt reduction, dividends or discretionary investment and makes the company more reliant on external financing over the medium term.

Suraksha Diagnostic Ltd. News

Suraksha Diagnostic’s Company Secretary and Compliance Officer Resigns

Suraksha Diagnostic Ltd. ( ($IN:SURAKSHA) ) has issued an update. Suraksha Diagnostic Limited has announced that Ms. Mamta...

26d ago

Suraksha Diagnostic Closes Trading Window Ahead of FY26 Results

An announcement from Suraksha Diagnostic Ltd. ( ($IN:SURAKSHA) ) is now available. Suraksha Diagnostic Limited has notified the...

4M ago

Suraksha Diagnostic CFO K S Ravindra to Step Down by May 31, 2026

Suraksha Diagnostic Ltd. ( ($IN:SURAKSHA) ) has issued an update. Suraksha Diagnostic Limited has announced that Group Chief...

4M ago

Suraksha Diagnostic Announces Trading Window Closure

Suraksha Diagnostic Ltd. ( ($IN:SURAKSHA) ) just unveiled an announcement. Suraksha Diagnostic Limited has announced the closure of...

10M ago

Suraksha Diagnostic to Present Q1 Financial Results in Upcoming Earnings Call

Suraksha Diagnostic Ltd. ( ($IN:SURAKSHA) ) has provided an update. Suraksha Diagnostic Limited announced an upcoming Investor Presentation...

11M ago

Suraksha Diagnostic Ltd. Releases Unaudited Financial Results

Suraksha Diagnostic Ltd. ( ($IN:SURAKSHA) ) just unveiled an update. Suraksha Diagnostic Ltd. has published its unaudited financial...

1y ago

SURAKSHA FAQ

What was Suraksha Diagnostic Ltd.’s price range in the past 12 months?

Suraksha Diagnostic Ltd. lowest stock price was ₹224.10 and its highest was ₹333.65 in the past 12 months.

What is Suraksha Diagnostic Ltd.’s market cap?

Suraksha Diagnostic Ltd.’s market cap is ₹14.25B.

When is Suraksha Diagnostic Ltd.’s upcoming earnings report date?

Suraksha Diagnostic Ltd.’s upcoming earnings report date is Aug 07, 2026 which is in 33 days.

How were Suraksha Diagnostic Ltd.’s earnings last quarter?

Suraksha Diagnostic Ltd. released its earnings results on May 21, 2026. The company reported ₹1.21 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.21.

Is Suraksha Diagnostic Ltd. overvalued?

According to Wall Street analysts Suraksha Diagnostic Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Suraksha Diagnostic Ltd. pay dividends?

Suraksha Diagnostic Ltd. pays a N/A dividend of ₹0.5 which represents an annual dividend yield of N/A. See more information on Suraksha Diagnostic Ltd. dividends here

What is Suraksha Diagnostic Ltd.’s EPS estimate?

Suraksha Diagnostic Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Suraksha Diagnostic Ltd. have?

Suraksha Diagnostic Ltd. has 52,080,757 shares outstanding.

What happened to Suraksha Diagnostic Ltd.’s price movement after its last earnings report?

Suraksha Diagnostic Ltd. reported an EPS of ₹1.21 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.73%.

Which hedge fund is a major shareholder of Suraksha Diagnostic Ltd.?

Currently, no hedge funds are holding shares in IN:SURAKSHA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Suraksha Diagnostic Ltd.

Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping; and radiology testing that includes X ray, magnetic resonance imaging, computed tomography scan, USG, DEXA scan, OPG, and mammography. The company also provides Cardiology testing services comprises electrocardiogram, echocardiogram, stress test / treadmill test, wireless holter monitoring, colour doppler, peripheral doppler, and pulmonary function test; gastroenterology, such as upper and lower GI endoscopy, sigmoidoscopy, proctoscopy, colonoscopy, and proctosigmoidoscopy; and neurology testing services, including electroencephalogram, electromyography, and nerve conduction velocity test. In addition, the company provides dental, physiotherapy, immunology & rheumatology, eye, fetal care, ENT, and speciality clinics, as well as home doctor visit services. The company was founded in 1992 and is based in Kolkata, India.